Drug Approval | April 23, 2025
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
Rising demands and advancements in eye care drive growth
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Bloom has pioneered a technology to transform plant waste into valuable chemical products
According to IQVIA sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) market achieved annual sales of approximately $39.3 mn
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Subscribe To Our Newsletter & Stay Updated
